SERA PROGNOSTICS, INC. Increase (Decrease) in Other Receivables
SERA PROGNOSTICS, INC. (SERA) reported Increase (Decrease) in Other Receivables of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-12
- SERA PROGNOSTICS, INC. increase (decrease) in other receivables for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SERA PROGNOSTICS, INC. increase (decrease) in other receivables for the quarter ending 2025-09-30 was $0.00.
- SERA PROGNOSTICS, INC. increase (decrease) in other receivables for the quarter ending 2025-06-30 was -$19.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in other receivables for the quarter ending 2025-03-31 was $0.00.
- SERA PROGNOSTICS, INC. increase (decrease) in other receivables for fiscal 2025 was -$19.00K.
- SERA PROGNOSTICS, INC. increase (decrease) in other receivables for fiscal 2024 was -$11.29M, a 312.64% decline from fiscal 2023.
- SERA PROGNOSTICS, INC. increase (decrease) in other receivables for fiscal 2023 was $5.31M, a 84.12% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. increase (decrease) in other receivables for fiscal 2022 was $2.88M, a 7.45% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $0.00 derived: sum of 2 quarters · filed 2026-03-18 | -$19.00K derived: sum of 3 quarters · filed 2026-08-12 | -$19.00K 10-K · filed 2026-03-18 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$19.00K derived: sum of 2 quarters · filed 2026-08-12 | -$19.00K 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$19.00K 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $19.00K derived: sum of 2 quarters · filed 2026-03-18 | $19.00K derived: sum of 3 quarters · filed 2026-03-18 | $19.00K derived: sum of 4 quarters · filed 2026-03-18 |
| 2024-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $19.00K derived: sum of 2 quarters · filed 2026-03-18 | $19.00K derived: sum of 3 quarters · filed 2026-03-18 | -$11.29M 10-K · filed 2026-03-18 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | -$11.31M 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$11.31M 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2025-08-06 | $0.00 derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$11.31M 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-05-07 | $0.00 derived: sum of 3 quarters · filed 2025-05-07 | $0.00 derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $11.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $11.31M derived: sum of 2 quarters · filed 2025-03-19 | $11.31M derived: sum of 3 quarters · filed 2025-03-19 | $5.31M 10-K · filed 2025-03-19 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | -$6.00M 10-Q · filed 2024-11-06 | $0.00 derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$6.00M 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2024-08-07 | $0.00 derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$6.00M 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2024-05-08 | $0.00 derived: sum of 3 quarters · filed 2024-05-08 | $0.00 derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $6.00M derived: sum of 2 quarters · filed 2024-03-20 | $6.00M derived: sum of 3 quarters · filed 2024-03-20 | $2.88M 10-K · filed 2024-03-20 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | -$3.12M 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$3.12M 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-08-09 | $0.00 derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$3.12M 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-05-10 | $0.00 derived: sum of 3 quarters · filed 2023-05-10 | $0.00 derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.12M derived: sum of 2 quarters · filed 2023-03-22 | $3.12M derived: sum of 3 quarters · filed 2023-03-22 | $3.12M 10-K · filed 2023-03-22 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |